CRISPR Snips Away Extra Chromosomes, Offering New Hope for Down Syndrome Treatment
Scientists are exploring gene editing as a way to correct trisomy at the cellular level. Using CRISPR-Cas9, researchers ...
ERS Genomics: European Patent Office Grants CVC Portfolio Key CRISPR Patent
ERS Genomics ('ERS'), which was established to provide broad access to the foundational CRISPR/Cas9 intellectual property ...
Engineering medicine: The future of CAR-T and CRISPR technologies
The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...
AZoLifeSciences on MSN13 天
CRISPR-Cas9 Off-Target Effects: Challenges and Solutions
The CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...
CRISPR: From Discovery To Clinic—And Charting A Path Forward
No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...
AZoLifeSciences on MSN7 天
Using CRISPR-Cas9 Gene Editing for Chromosomal Rescue in Down Syndrome
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...
Using CRISPR to remove extra chromosomes in Down syndrome
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...
Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future
Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...
Frontiers19 天
Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
Since their discovery, the stem cell (SC) field achieved significant milestones and opened several gateways in the area of disease modeling, drug discovery, and regenerative medicine. In parallel, the ...
Bahrain conducts 1st CRISPR-based sickle cell treatment outside U.S.
Bahrain has achieved a medical milestone by successfully treating a patient with sickle cell disease (SCD) using ...